These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31471594)

  • 1. Synthesis and biological activity of analogs of CPZEN-45, a novel antituberculosis drug.
    Ishizaki Y; Takahashi Y; Kimura T; Inoue M; Hayashi C; Igarashi M
    J Antibiot (Tokyo); 2019 Dec; 72(12):970-980. PubMed ID: 31471594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45.
    Ishizaki Y; Hayashi C; Inoue K; Igarashi M; Takahashi Y; Pujari V; Crick DC; Brennan PJ; Nomoto A
    J Biol Chem; 2013 Oct; 288(42):30309-30319. PubMed ID: 23986448
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Huszár S; Singh V; Polčicová A; Baráth P; Barrio MB; Lagrange S; Leblanc V; Nacy CA; Mizrahi V; Mikušová K
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents.
    Hirano S; Ichikawa S; Matsuda A
    Bioorg Med Chem; 2008 May; 16(9):5123-33. PubMed ID: 18375127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and evaluation of multicaulin and miltirone-like compounds as antituberculosis agents.
    Burmaoğlu S; Seçinti H; Mozioğlu E; Gören AC; Altundaş R; Seçen H
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):878-884. PubMed ID: 28661186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caprazamycins: Biosynthesis and structure activity relationship studies.
    Wiker F; Hauck N; Grond S; Gust B
    Int J Med Microbiol; 2019 Jul; 309(5):319-324. PubMed ID: 31138496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase.
    Mao J; Eoh H; He R; Wang Y; Wan B; Franzblau SG; Crick DC; Kozikowski AP
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5320-3. PubMed ID: 18783951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis from tigogenin and antituberculosis activity of some of the derivatives of 5alpha-ketosteroid hydrazones].
    Merlani MI; Kemertelidze EP; Popandopoulos K; Men'shova NI
    Bioorg Khim; 2004; 30(5):552-7. PubMed ID: 15562978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.
    Matviiuk T; Mori G; Lherbet C; Rodriguez F; Pasca MR; Gorichko M; Guidetti B; Voitenko Z; Baltas M
    Eur J Med Chem; 2014 Jan; 71():46-52. PubMed ID: 24269516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.
    Patel B; Ryan P; Makwana V; Zunk M; Rudrawar S; Grant G
    Eur J Med Chem; 2019 Jun; 171():462-474. PubMed ID: 30933853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors.
    Mitachi K; Siricilla S; Yang D; Kong Y; Skorupinska-Tudek K; Swiezewska E; Franzblau SG; Kurosu M
    Anal Biochem; 2016 Nov; 512():78-90. PubMed ID: 27530653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase MraY with a β-ketophosphonate structure.
    Auberger N; Frlan R; Al-Dabbagh B; Bouhss A; Crouvoisier M; Gravier-Pelletier C; Le Merrer Y
    Org Biomol Chem; 2011 Dec; 9(24):8301-12. PubMed ID: 22042341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
    Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
    Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.
    Wang X; Zhao W; Wang B; Ding W; Guo H; Zhao H; Meng J; Liu S; Lu Y; Liu Y; Zhang D
    Bioorg Chem; 2021 Sep; 114():105110. PubMed ID: 34175719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical in vitro characterization of CPZEN-45, a drug candidate for inhalation therapy of tuberculosis.
    Salomon JJ; Galeron P; Schulte N; Morow PR; Severynse-Stevens D; Huwer H; Daum N; Lehr CM; Hickey AJ; Ehrhardt C
    Ther Deliv; 2013 Aug; 4(8):915-23. PubMed ID: 23919471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
    Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
    Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure.
    Wu C; Luo J; Wu M; Meng F; Cai Z; Chen Y; Sun T
    Med Chem; 2020; 16(5):703-714. PubMed ID: 31203803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents.
    Huang Q; Kirikae F; Kirikae T; Pepe A; Amin A; Respicio L; Slayden RA; Tonge PJ; Ojima I
    J Med Chem; 2006 Jan; 49(2):463-6. PubMed ID: 16420032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity.
    Takahashi Y; Igarashi M; Miyake T; Soutome H; Ishikawa K; Komatsuki Y; Koyama Y; Nakagawa N; Hattori S; Inoue K; Doi N; Akamatsu Y
    J Antibiot (Tokyo); 2013 Mar; 66(3):171-8. PubMed ID: 23532021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.